Immune Cell Metabolism in Tumor Microenvironment

被引：26
作者：
Li, Yongslieng [1 ]
Wan, Yisong Y. [2 ]
Zhu, Bo [1 ]
机构：
[1] Third Mil Med Univ, Xinqiao Hosp, Inst Canc, Chongqing, Peoples R China
[2] Univ North Carolina Chapel Hill, Lineberger Comprehen Canc Ctr, Chapel Hill, NC USA
来源：
IMMUNE METABOLISM IN HEALTH AND TUMOR | 2017年 / 1011卷
关键词：
Immune cell metabolism; Tumor microenvironment; Cancer stein cells; Clinical diagnosis; Drug repositioning; FATTY-ACID OXIDATION; CANCER-ASSOCIATED FIBROBLASTS; HUMAN DENDRITIC CELLS; REGULATORY T-CELLS; PYRUVATE-KINASE M2; SUPPRESSOR-CELLS; NITRIC-OXIDE; MACROPHAGE POLARIZATION; ALTERNATIVE ACTIVATION; GLUTAMINE-METABOLISM;
D O I：
10.1007/978-94-024-1170-6_5
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Tumor microenvironment (TME) is composed of tumor cells, immune cells, cytokines, extracellular matrix, etc. The immune system and the metabolisms of glucose, lipids, amino acids, and nucleotides are integrated in the tumorigenesis and development. Cancer cells and immune cells show metabolic reprogramming in the TME, which intimately links immune cell functions and edits tumor immunology. Recent findings in immune cell metabolism hold the promising possibilities toward clinical therapeutics for treating cancer. This chapter introduces the updated understandings of metabolic reprogramming of immune cells in the TME and suggests new directions in manipulation of immune responses for cancer diagnosis and therapy.
引用
收藏
页码：163 / 196
页数：34
相关论文
共 265 条
  • [91] Cancer Stem Cell-Specific Scavenger Receptor CD36 Drives Glioblastoma Progression
    Hale, James S.
    Otvos, Balint
    Sinyuk, Maksim
    Alvarado, Alvaro G.
    Hitomi, Masahiro
    Stoltz, Kevin
    Wu, Qiulian
    Flavahan, William
    Levison, Bruce
    Johansen, Mette L.
    Schmitt, David
    Neltner, Janna M.
    Huang, Ping
    Ren, Bin
    Sloan, Andrew E.
    Silverstein, Roy L.
    Gladson, Candece L.
    DiDonato, Joseph A.
    Brown, J. Mark
    McIntyre, Thomas
    Hazen, Stanley L.
    Horbinski, Craig
    Rich, Jeremy N.
    Lathia, Justin D.
    [J]. STEM CELLS, 2014, 32 (07) : 1746 - 1758
  • [92] A role for class A scavenger receptor in dendritic cell nibbling from live cells
    Harshyne, LA
    Zimmer, MI
    Watkins, SC
    Barratt-Boyes, SM
    [J]. JOURNAL OF IMMUNOLOGY, 2003, 170 (05) : 2302 - 2309
  • [93] Combinatorial Cancer Immunotherapies
    Hellmann, Matthew D.
    Friedman, Claire F.
    Wolchok, Jedd D.
    [J]. TUMOR IMMUNOLOGY, 2016, 130 : 251 - 277
  • [94] Tumor angiogenesis-characteristics of tumor endothelial cells
    Hida, Kyoko
    Maishi, Nako
    Torii, Chisaho
    Hida, Yasuhiro
    [J]. INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2016, 21 (02) : 206 - 212
  • [95] Ho Victor W. H., 2009, V531, P173, DOI 10.1007/978-1-59745-396-7_12
  • [96] Inhibition of Fatty Acid Oxidation Modulates Immunosuppressive Functions of Myeloid-Derived Suppressor Cells and Enhances Cancer Therapies
    Hossain, Fokhrul
    Al-Khami, Amir A.
    Wyczechowska, Dorota
    Hernandez, Claudia
    Zheng, Liqin
    Reiss, Krzystoff
    Del Valle, Luis
    Trillo-Tinoco, Jimena
    Maj, Tomasz
    Zou, Weiping
    Rodriguez, Paulo C.
    Ochoa, Augusto C.
    [J]. CANCER IMMUNOLOGY RESEARCH, 2015, 3 (11) : 1236 - 1247
  • [97] mTOR couples cellular nutrient sensing to organismal metabolic homeostasis
    Howell, Jessica J.
    Manning, Brendan D.
    [J]. TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2011, 22 (03) : 94 - 102
  • [98] Cell-intrinsic lysosomal lipolysis is essential for alternative activation of macrophages
    Huang, Stanley Ching-Cheng
    Everts, Bart
    Ivanova, Yulia
    O'Sullivan, David
    Nascimento, Marcia
    Smith, Amber M.
    Beatty, Wandy
    Love-Gregory, Latisha
    Lam, Wing Y.
    O'Neil, Christina M.
    Yan, Cong
    Du, Hong
    Abumrad, Nada A.
    Urban, Joseph F., Jr.
    Artyomov, Maxim N.
    Pearce, Erika L.
    Pearce, Edward J.
    [J]. NATURE IMMUNOLOGY, 2014, 15 (09) : 846 - 855
  • [99] Costimulation, coinhibition and cancer
    Inman, Brant A.
    Frigola, Xavier
    Dong, Haidong
    Kwon, Eugene D.
    [J]. CURRENT CANCER DRUG TARGETS, 2007, 7 (01) : 15 - 30
  • [100] CD44 Variant Regulates Redox Status in Cancer Cells by Stabilizing the xCT Subunit of System xc- and Thereby Promotes Tumor Growth
    Ishimoto, Takatsugu
    Nagano, Osamu
    Yae, Toshifumi
    Tamada, Mayumi
    Motohara, Takeshi
    Oshima, Hiroko
    Oshima, Masanobu
    Ikeda, Tatsuya
    Asaba, Rika
    Yagi, Hideki
    Masuko, Takashi
    Shimizu, Takatsune
    Ishikawa, Tomoki
    Kai, Kazuharu
    Takahashi, Eri
    Imamura, Yu
    Baba, Yoshifumi
    Ohmura, Mitsuyo
    Suematsu, Makoto
    Baba, Hideo
    Saya, Hideyuki
    [J]. CANCER CELL, 2011, 19 (03) : 387 - 400
567891011121314